Prognos is a healthcare AI company focused on eradicating disease by driving decisions earlier in healthcare in collaboration with payers, Life Sciences and diagnostics companies. The Prognos Registry is the largest source of clinical diagnostics information in over 30 disease areas, with over 7B medical records for 150M patients. Prognos has 500 extensive proprietary and learning clinical algorithms to enable earlier patient identification for enhanced treatment decision-making, risk management and quality improvement. The company is supported by a $23M investment from Safeguard Scientifics, Inc. (NYSE:SFE) and Merck Global Health Innovation Fund (GHIF). For more information, visit www.prognos.ai. Mission:?Tracking and predicting disease the earliest to improve health.
51 to 200
TypeCompany - Private
Revenue$10 to $25 million (USD) per year
IndustryHealth Care Services & Hospitals
CompetitorsUnknown
Founded2010